Anuh Pharma Regulatory Approval

Promoter Reclassification

Anuh Pharma Promoter Reclassification

Anuh Pharma's promoter group member Nina Vijay Shah withdrew her request to reclassify to the public category. She remains in the promoter group.

Financial Results

Anuh Pharma Q2 FY27 Results: Net Profit ₹11.2 Cr, Up 47.4% YoY

Anuh Pharma Ltd reported revenue from operations of ₹185.2 Cr (-0.4% YoY) and net profit of ₹11.2 Cr (+47.4% YoY) for Q2 FY27.

Key figure

Net profit ₹11.2 Cr · +47.4% YoY

Board Meeting Date

Anuh Pharma Board Meeting Date

Anuh Pharma's board meets on 30 October 2026 to approve Q1/H1 FY27 results. Trading window closed for insiders until 1 November 2026.

Acquisition

Anuh Pharma Acquisition Worth ₹72.9 Cr

Anuh Pharma signed an Asset Transfer Agreement to acquire a manufacturing facility from Vanquest Pharma for ₹72.90 Crore, increasing its production capacity by 525 MTPA.

Value

₹72.90 Cr

manufacturing capacity

525.0 MTPA

Debt & Borrowing

Anuh Pharma Debt & Borrowing: ₹75 Cr

Anuh Pharma Ltd board approved a loan of ₹75 Crore to finance manufacturing asset investments for expanding production capacity.

Value

₹75.00 Cr

Other Announcement

Anuh Pharma Other Announcement

Anuh Pharma Ltd filed the quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, as issued by its RTA.

Regulatory ApprovalGrasim Industries Ltd GRASIMAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Grasim Industries Regulatory Approval

CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.

Regulatory ApprovalVedavaag Systems Ltd VEDAVAAG

Vedavaag Systems Regulatory Approval

Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.

Regulatory ApprovalHikal Ltd HIKALAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Hikal Regulatory Approval

Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.

Regulatory ApprovalSun Pharmaceutical Industries Ltd SUNPHARMAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sun Pharmaceutical Industries Regulatory Approval

Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.

Regulatory ApprovalRNFI Services Ltd RNFIAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

RNFI Services Regulatory Approval

RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.